Text Size
- News Releases
- What's New
- 19 Oct
- Chugai and Welby Launch a Treatment Support Personal Health Record Service for Cancer Patients to Promote Proper Use of Tecentriq
- 15 Oct
- F. Hoffmann-La Roche Announces Third Quarter Sales 2020
- 15 Oct
- Chugai Files a New Drug Application for Risdiplam as the First Oral Drug for Spinal Muscular Atrophy in Japan
- 06 Oct
- Chugai Enters into a License Agreement for Chugai’s Antibody Engineering Technologies with argenx
- 02 Oct
- Chugai Files for Expanded Use of FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic for Pemigatinib for Patients with FGFR2 Fusion Positive Locally Advanced or Metastatic Cholangiocarcinoma
Video Introduction of CHUGAI- Share this site
